Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/24/2013US20130280337 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
10/24/2013US20130280336 Nanoparticle comprising rapamycin and albumin as anticancer agent
10/24/2013US20130280335 Biomedical implants comprising surface-modified ceramic particles and biodegradable stereo complex polymers, its use for suppressing inflammation and improvement of mechanical property, and preparation method thereof
10/24/2013US20130280333 Compositions containing ultra-micronized palmitoyl-ethanolamide
10/24/2013US20130280330 Microsphere drug carrier, preparation method, composition and use thereof
10/24/2013US20130280329 Methods and compositions for rnai-based cancer treatment
10/24/2013US20130280328 Treatment of inflammatory bowel disease with 6-mercaptopurine
10/24/2013US20130280324 Sustained release pharmaceutical compositions comprising pregabalin
10/24/2013US20130280323 Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
10/24/2013US20130280309 Foamable suspension gel
10/24/2013US20130280308 Pharmaceutical compositions of anti-acne agents
10/24/2013US20130280303 Bone delivery system having a therapeutic agent
10/24/2013US20130280286 Medicament for lct poisoning
10/24/2013US20130280270 Methods of treating lung disease and other inflammatory diseases
10/24/2013US20130280258 Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents
10/24/2013US20130280254 Macrophage-synthesized ccl3 promotes breast cancer metastasis
10/24/2013US20130280252 Method for selecting patient to be given drug for treating septicemia
10/24/2013US20130280251 Stabilized Angiopoietin-2 Antibodies And Uses Thereof
10/24/2013US20130280245 3-Aryl-6-aryl-[1,2,4]triazolo[4,3-alpha]pyridines as Inhibitors of Cell Proliferation and the Use Thereof
10/24/2013US20130280243 COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR
10/24/2013US20130280242 Method of plscr inhibition for cancer therapy
10/24/2013US20130280241 15-pgdh in colon cancer
10/24/2013US20130280233 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
10/24/2013US20130280227 Functional food preparation and use thereof
10/24/2013US20130280223 Functionalized tissue matrices
10/24/2013US20130280214 Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases
10/24/2013US20130280213 Estriol therapy for multiple sclerosis and other autoimmune diseases
10/24/2013US20130280212 Inhibitors of cytochrome p450
10/24/2013US20130280211 Hepatitis C Virus Inhibitors
10/24/2013US20130280210 Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
10/24/2013US20130280189 Personal care and health care compositions
10/24/2013US20130276779 Method of forming an aerosol for inhalation delivery
10/24/2013DE102012103405A1 New disubstituted heteroaryl compound useful for treating a disease consisting of viral diseases, proliferative diseases, neurodegenerative diseases, diabetes, malaria, and HIV infection
10/24/2013CA2861060A1 New phenyl-tetrahydroisoquinoline derivatives
10/24/2013CA2850881A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/23/2013EP2653475A1 Method for producing 2-o- alpha-d-glucosyl-l-ascorbic acid anhydrous crystal-containing powder
10/23/2013EP2653473A1 Fused Aminodihydro-Oxazine Derivatives
10/23/2013EP2653469A1 Pyrazole derivative
10/23/2013EP2653468A1 Bicyclic Compound and Use Thereof for Medical Purposes
10/23/2013EP2653466A1 Agents for treating disorders involving modulation of ryanodine receptors
10/23/2013EP2653465A1 Opioid receptor modulators
10/23/2013EP2653193A1 Method for treating macular degeneration
10/23/2013EP2653166A2 Pharmaceutical composition and related methods
10/23/2013EP2653164A1 Type 5 and type 8 capsular polysaccharides of over-productive strains of S. aureus
10/23/2013EP2653163A1 Estrogenic components for use in the treatment of neurological disorders
10/23/2013EP2653162A1 Methods of administering fluvoxamine therapy
10/23/2013EP2653161A1 Use of lipoic acid for maintaining or increasing bone mineral density in companion animals
10/23/2013EP2653160A1 Topical avermectin formulations and methods for elimination and prophylaxis of body lice
10/23/2013EP2653159A1 Bromfenac organic salts and preparation method, composition and use thereof
10/23/2013EP2653158A1 Therapeutic agent for blood-brain barrier disruption syndrome
10/23/2013EP2653157A1 Astaxanthin for improving muscle atrophy
10/23/2013EP2653155A1 Ophthalmic composition for contact lens
10/23/2013EP2653154A1 Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators
10/23/2013EP2653153A1 Anti-malarial pharmaceutical composition
10/23/2013EP2653152A1 Pharmaceutical compositions for sublingual delivery of opioids
10/23/2013EP2652655A1 Methods and models for predicting dosage of a drug and/or response in an individual
10/23/2013EP2652506A2 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
10/23/2013EP2652137A1 Lar protein-specific ligand
10/23/2013EP2652136A1 Nucleic acids targeting tctp for use in the treatment of chemo-or hormone-resistant cancers
10/23/2013EP2652135A1 The abcg1 gene as a marker and a target gene for treating obesity
10/23/2013EP2651959A2 Aminoglycosides:synthesis and use as antifungals
10/23/2013EP2651957A1 Phosphorous derivatives as chemokine receptor modulators
10/23/2013EP2651951A1 Tricyclic pi3k inhibitor compounds and methods of use
10/23/2013EP2651950A1 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651949A1 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
10/23/2013EP2651948A1 Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders
10/23/2013EP2651947A1 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651946A1 2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651945A1 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651944A1 Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651943A1 Purine derivatives
10/23/2013EP2651941A1 Inhibitors of influenza viruses replication
10/23/2013EP2651940A1 Inhibitors of influenza viruses replication
10/23/2013EP2651939A1 SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
10/23/2013EP2651938A1 Inhibitors of influenza viruses replication
10/23/2013EP2651937A1 Imidazo [4, 5 -c]quinolin- 1 -yl derivative useful in therapy
10/23/2013EP2651936A1 Azaindoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651934A1 Imidazopyridines as respiratory syncytial virus antiviral agents
10/23/2013EP2651933A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651932A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
10/23/2013EP2651931A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
10/23/2013EP2651930A1 Biarylamide inhibitors of leukotriene production
10/23/2013EP2651929A1 Novel benzofurane compounds
10/23/2013EP2651928A2 Anti-viral compounds
10/23/2013EP2651927A1 Anti-viral compounds
10/23/2013EP2651926A2 Anti-viral compounds
10/23/2013EP2651925A2 Anti-viral compounds
10/23/2013EP2651924A1 Anti-viral compounds
10/23/2013EP2651923A1 Anti-viral compounds
10/23/2013EP2651922A1 Indoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651920A2 Anti-viral compounds
10/23/2013EP2651919A1 Dimeric iap inhibitors
10/23/2013EP2651918A1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
10/23/2013EP2651917A1 Dimeric iap inhibitors
10/23/2013EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
10/23/2013EP2651915A1 Continuous arycyclic compound
10/23/2013EP2651906A1 Inhibitors of hepatitis c virus polymerase
10/23/2013EP2651903A1 Benzimidazole respiratory syncytial virus inhibitors
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651899A2 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
1 ... 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 ... 7860